What inversion Celcuity CELC AbbVie Inc ABBV Former Senior Immunology RD Leader Anthony Slavin Appointed SVP of Portfolio Strategy at Infinimmune CVE Cenovus posts 281 percent Q4 2025 EPS beat even as shares dip 06 percent in todays trading